ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts 실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.
Anebulo Pharmaceuticals Inc

Anebulo Pharmaceuticals Inc (ANEB)

1.53
-0.07
(-4.38%)
종가: 05 2월 6:00AM
1.53
0.00
( 0.00% )
시간외 거래: 6:39AM

실시간 토론 및 거래 아이디어: 강력한 플랫폼으로 자신있게 거래하세요.

주요 통계 및 세부정보

가격
1.53
매수가
1.46
매도가
1.90
거래량
1,859
1.4709 일간 변동폭 1.58
0.8001 52주 범위 3.30
market_cap
전일 종가
1.60
개장가
1.57
최근 거래 시간
2
@
1.52
마지막 거래 시간
06:00:00
재정 규모
US$ 2,799
VWAP
1.5059
평균 볼륨(3m)
31,956
발행 주식
25,933,217
배당수익률
-
주가수익률
-4.84
주당순이익(EPS)
-0.32
매출
-
순이익
-8.2M

Anebulo Pharmaceuticals Inc 정보

Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company. It is developing novel solutions for people suffering from cannabinoid overdose and substance addiction. The product candidate, ANEB-001, is intended to reverse the negative effects of cannabinoid overdose within 1 hour of admini... Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company. It is developing novel solutions for people suffering from cannabinoid overdose and substance addiction. The product candidate, ANEB-001, is intended to reverse the negative effects of cannabinoid overdose within 1 hour of administration. The signs and symptoms of cannabinoid overdose range from profound sedation to anxiety and panic to psychosis with hallucinations. 더 보기

섹터
Pharmaceutical Preparations
산업
Pharmaceutical Preparations
웹사이트
본부
Dover, Delaware, USA
설립됨
-
Anebulo Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the 나스닥 with ticker ANEB. The last closing price for Anebulo Pharmaceuticals was US$1.60. Over the last year, Anebulo Pharmaceuticals shares have traded in a share price range of US$ 0.8001 to US$ 3.30.

Anebulo Pharmaceuticals currently has 25,933,217 shares in issue. The market capitalisation of Anebulo Pharmaceuticals is US$41.49 million. Anebulo Pharmaceuticals has a price to earnings ratio (PE ratio) of -4.84.

ANEB 최신 뉴스

Anebulo Pharmaceuticals Announces Positive Regulatory Update for Selonabant in Acute Cannabis-Induced Toxicity in Children and Capital Raise

Anebulo Pharmaceuticals, Inc. (Nasdaq: ANEB), a clinical-stage biopharmaceutical company developing novel solutions for people suffering from acute cannabinoid-induced toxicities (the “Company”...

Anebulo Pharmaceuticals Reports First Quarter Fiscal Year 2025 Financial Results and Recent Updates

Anebulo Pharmaceuticals, Inc. (Nasdaq: ANEB), a clinical-stage pharmaceutical company developing novel solutions for people suffering from acute cannabis-induced toxic effects (the “Company” or...

Anebulo Pharmaceuticals Reports Fourth Quarter and Fiscal Year 2024 Financial Results and Recent Updates

Anebulo Pharmaceuticals, Inc. (Nasdaq: ANEB), a clinical-stage biopharmaceutical company developing novel solutions for people suffering from acute cannabis-induced toxic effects (the “Company”...

Anebulo Pharmaceuticals Awarded NIDA Grant for its Investigational IV Treatment for Acute Cannabis-Induced Toxic Effects

Anebulo Pharmaceuticals, Inc. (Nasdaq: ANEB), a clinical-stage biopharmaceutical company developing novel solutions for people suffering from acute cannabis-induced toxic effects (the “Company”...

기간변동변동 %시가고가저가평균 일일 거래량VWAP
1-0.09-5.555555555561.621.74861.42198231.59779746CS
4-0.155-9.198813056381.6851.74861.39142771.57956871CS
12-0.1-6.134969325151.631.80.8001319561.411913CS
26-0.42-21.53846153851.953.080.8001183191.57858433CS
52-1.06-40.92664092662.593.30.8001121961.83698782CS
156-6.06-79.84189723327.597.880.8001105012.75021844CS
260-5.85-79.26829268297.389.330.8001112293.87702683CS

ANEB - Frequently Asked Questions (FAQ)

What is the current Anebulo Pharmaceuticals share price?
The current share price of Anebulo Pharmaceuticals is US$ 1.53
How many Anebulo Pharmaceuticals shares are in issue?
Anebulo Pharmaceuticals has 25,933,217 shares in issue
What is the market cap of Anebulo Pharmaceuticals?
The market capitalisation of Anebulo Pharmaceuticals is USD 41.49M
What is the 1 year trading range for Anebulo Pharmaceuticals share price?
Anebulo Pharmaceuticals has traded in the range of US$ 0.8001 to US$ 3.30 during the past year
What is the PE ratio of Anebulo Pharmaceuticals?
The price to earnings ratio of Anebulo Pharmaceuticals is -4.84
What is the reporting currency for Anebulo Pharmaceuticals?
Anebulo Pharmaceuticals reports financial results in USD
What is the latest annual profit for Anebulo Pharmaceuticals?
The latest annual profit of Anebulo Pharmaceuticals is USD -8.2M
What is the registered address of Anebulo Pharmaceuticals?
The registered address for Anebulo Pharmaceuticals is 838 WALKER ROAD, SUITE 21-2, KENT, DOVER, DELAWARE, 19904
What is the Anebulo Pharmaceuticals website address?
The website address for Anebulo Pharmaceuticals is www.anebulo.com
Which industry sector does Anebulo Pharmaceuticals operate in?
Anebulo Pharmaceuticals operates in the PHARMACEUTICAL PREPARATIONS sector

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
SFHGSamfine Creation Holdings Group Ltd
US$ 1.32
(32.00%)
3.8M
CYNCYNGN Inc
US$ 0.0872
(22.82%)
19.97M
NDRAENDRA Life Sciences Inc
US$ 5.84
(21.16%)
431
MRCYMercury Systems Inc
US$ 49.00
(16.42%)
25.15k
AVNWAviat Networks Inc
US$ 23.50
(14.36%)
44.09k
AMDLGraniteShares 2X Long AMD Daily ETF
US$ 6.0099
(-17.79%)
11.81M
AMDGLevrage Shares 2X Long AMD Daily ETF
US$ 11.56
(-17.04%)
53.91k
GGLLDirexion Daily GOOGL Bull 2X ETF
US$ 45.20
(-15.20%)
1.38M
SDASunCar Technology Group Inc
US$ 8.88
(-13.79%)
42.48k
INTAIntapp Inc
US$ 63.61
(-13.47%)
73.39k
AMDAdvanced Micro Devices Inc
US$ 108.87
(-8.90%)
20.59M
CYNCYNGN Inc
US$ 0.0872
(22.82%)
19.97M
AMDLGraniteShares 2X Long AMD Daily ETF
US$ 6.0099
(-17.79%)
11.81M
GOOGLAlphabet Inc
US$ 190.50
(-7.69%)
9.95M
NVDANVIDIA Corporation
US$ 119.05
(0.34%)
7.6M
SniffinPennies SniffinPennies 3 분 전
I read this as F'ed up

SEC rule 204SHO
“Naked” short selling is not necessarily a violation of the federal securities laws or the Commission’s rules. Indeed, in certain circumstances, “naked” short selling contributes to market liquidity. For example, broker-dealers that make a
CGAC
Stinger2014 Stinger2014 3 분 전
Just a Q, isn’t dilution a sell to the bid? TIA!
CGAC
RickNagra RickNagra 3 분 전
The big beautiful bill.
FNMA
ironhammer ironhammer 4 분 전
this is a list of MM signals

1. 100 - I need Shares.
2. 200 - I need Shares badly but do not take the stock down.
3. 300 - Take (or I am taking) the stock down at least 30% so I can load shares.
4. 400 - Keep trading it sideways.
5. 500 - Gap the stock. Ga
NBRI
jimr1717 jimr1717 5 분 전
Noted and Correct and lots more to come
HMBL
OnTrack444 OnTrack444 5 분 전
I played the pump but then GTFO after the dilution reared its head and billions of shares were being traded intraday without SP movement up!  It's all about timing but the pig has been fed!  Game over! 
HMBL
Number sleven Number sleven 5 분 전
Seve/Mike, Why do you think he was referring to you?
Sleven,
AMRN
$Gambler $Gambler 5 분 전
Well, if we see them really heat up, it could be some good news is coming.
CGAC
DiamondHealer95 DiamondHealer95 5 분 전
Funny, nobody saw it when I said it 6 months before you. They all saw you said June.
KBLB
8lang 8lang 7 분 전
4502 02/04/2025 SUPPLEMENTAL REPLY MEMORANDUM OF LAW in Support re: [4164] JOINT MOTION for Summary Judgment on "Upstream" Issues. Document filed by JPMorgan Chase Bank, N.A., JPMorgan Chase & Co.
4501 02/04/2025***SELECTED PARTIES***DECLAR
stink stack stink stack 7 분 전
Go away... You don't get my dry humor, and you probably don't fully understand anything. TROLL
FNMA
getmoreshares getmoreshares 7 분 전
unless the rules have changed- co must buy at the bid and sell at the ask
CGAC
learningcurve2020 learningcurve2020 8 분 전
And, this is why I keep saying that approval will likely wait for NICE, if it ever happens.

>>The committee meeting planned for 12 February 2025 will be rescheduled and the timelines for this appraisal will be revised to ensure they align with regulatory timings. We will provide a fur
NWBO
price_and_volume price_and_volume 8 분 전
Lol, I guess my post was too long?
By the MM’s. Take the time and look at L2 during trading hours or maybe you are another one that is 20 minutes delayed. Dude I trade for a living. I have an awareness of how & why prices move. This is the post you're replying to: Everyone here claims to have
HMBL
ScottishTexan ScottishTexan 9 분 전
Limiting your posts to 1 a day was a great move.
RNVA
DiamondHealer95 DiamondHealer95 9 분 전
He gets all the credit but I said it 6 months before him

I love the way people think today
KBLB
Midwestrader Midwestrader 9 분 전
SERIAL DUMPER MATTY BOY DUMPS at least 190,000 SHARES today. He DUMPED at least 100,000 yesterday.

DUMP MATTY DUMP!!!!
INND
100lbStriper 100lbStriper 9 분 전
how things work out after we get paid is another story. whose to say they dont continue to infringe and we end up in court again. unless of course scamsong negotiates a license. dont worry about not being well versed in patent law unless you intend to make a career out of it. what little i know or e
NLST
DiamondHealer95 DiamondHealer95 10 분 전
I'm still banking on February but we're running out of days. I'm with you on the +/- 2 months.

Truth, bum, he said OPEN FOR BUSINESS AT 1.5 METRIC TONS.

TO BE SO LAZY AS TO NOT VERIFY A SIMPLE FACT FROM A VIDEO IS PATHETIC. YOU SUCK
KBLB
Penny2Dime Penny2Dime 10 분 전
Fasten your seat belt!
CYCA
EmpressMonk25 EmpressMonk25 10 분 전
Another user who displayed no prior interest in HUMBL before the surge on December 3rd... some individuals are behaving like flies attracted to food when it appears.
HMBL
theorysuit theorysuit 10 분 전
Then you wake up and realize this volume and see this has 1.4B outstanding share count. LMFAO.
NWBO